Deescalation, discontinuation, and deimplementation trials have emerged in multiple health care contexts in which interventions are suspected of being inappropriately used, applied beyond their…

CONCLUSIONS: A minority of PICU admissions following T/A procedures require urgent or emergent interventions. This suggests that deimplementation of routine T/A PICU admissions may facilitate transitioning patients to the inpatient unit, reducing costs and optimizing PICU use.

Deescalation, discontinuation, and deimplementation trials have emerged in multiple health care contexts in which interventions are suspected of being inappropriately used, applied beyond their eviden...

Deescalation, discontinuation, and deimplementation trials have emerged in multiple health care contexts in which interventions are suspected of being inappropriately used, applied beyond their eviden...

Deescalation, discontinuation, and deimplementation trials have emerged in multiple health care contexts in which interventions are suspected of being inappropriately used, applied beyond their eviden...

Safer Supply Programs in Canada: Rise, Fall, and Public Health Implications Key Highlights Medicine · Public Health · Health Policy This Viewpoint from JAMA Health Forum critically examines the implementation and subsequent deimplementation of safer supply programs in Canada, which provided pharmaceutical-grade medications to individuals using unregulated substances, particularly opioids. The article analyzes the policy factors and evidence base that led to the rise and then the rollback of these harm reduction initiatives across Canadian provinces.

The Rise and Fall of Safer Supply Programs in Canada Key Highlights Medicine · Public Health This Viewpoint article critically examines the trajectory of safer supply programs in Canada, which were designed to provide pharmaceutical-grade medications to individuals using unregulated opioids. The analysis details the factors that led to the implementation of these harm reduction initiatives and the subsequent political and public health pressures that drove their deimplementation.

In which we interview Rani Elwy about her work at the intersection of implementation science and policy as she served as a Robert Wood Johnson health policy fellow in the US Senate focusing on menopau...